Connect with us
Sequentia Biotech plans to use new funds to expand its Mick-branded application for automated microbiome data analysis, targeting biopharmaceutical and biomedical sectors. The biotech, founded in...
Asabys Partners closed its second fund, Sahii II, at €180 million, surpassing the initial €150 million target. Supported by Banco Sabadell and other international investors, Sahii...
Multiply Labs has secured its first major collaboration with Legend Biotech to use robotic technology in cell therapy manufacturing. The partnership aims to improve efficiency and...
Brain Biotech shares surged 85%, fueled by news of a major deal with Royalty Pharma. However, the contract's full value, €128.88 million, is conditional on meeting...
Sysmex is advancing a five-year growth plan in Spain, expecting a 10% revenue increase in 2024. Key milestones include new hematology systems and partnerships, organic market...
Alfasigma, an Italian pharmaceutical company, absorbed Galapagos' Spanish subsidiary in September after board restructuring in June. The merger required regulatory clearance, which was not fully met,...
Luminova Pharma Group plans to invest heavily in modernizing and expanding Serra Pàmies laboratories in Reus to boost production of cardiovascular, diabetes, and psychotropic treatments. The...
Novo Nordisk's experimental weight-loss pill, amycretin, showed promising early-phase results, with patients losing up to 13.1% of their weight in 12 weeks. Side effects were mild...
The global 4K medical imaging market is projected to reach $2.37 billion by 2032, driven by a 10.44% CAGR. Growth is fueled by rising chronic diseases,...
Oryzon Genomics' stock rose over 3% after announcing progress in a leukemia study. The first patient received a dose in a Phase Ib trial of iadademstat...